Distinctive blood eosinophilic phenotypes and cytokine patterns in eosinophilic esophagitis, inflammatory Bowel disease and airway allergy

Journal of Innate Immunity

Volumn 3, Issue 6, 2011, Pages 594-604

  Johnsson, Marianne ^a   Bove, Mogens ^b   Bergquist, Henrik ^a   Olsson, Mikael ^b   Fornwall, Sven ^c   Hassel, Karin ^c   Wold, Agnes E ^a   Wennerås, Christine ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b NAL Hospital   (Sweden)

^c Norrmalm Primary Health Care Center   (Sweden)

Author keywords

Cytokines; Eosinophilic esophagitis; Eosinophils; Flow cytometry; Inflammatory bowel disease

Indexed keywords

CD23 ANTIGEN; CHEMOKINE RECEPTOR CCR3; CRTH2 ANTIGEN; CYTOKINE; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 5; RANTES; UNCLASSIFIED DRUG;

ADULT; ALLERGY; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTERITIS; EOSINOPHIL COUNT; EOSINOPHILIC ESOPHAGITIS; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; ANTIGENS, CD; CELL COUNT; CELL DIFFERENTIATION; CELL SEPARATION; CELLULAR MICROENVIRONMENT; CYTOKINES; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; RESPIRATORY HYPERSENSITIVITY;

EID: 80054923005     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000331326     Document Type: Article

References (40)

1. Bischoff SC, Wedemeyer J, Herrmann A, Meier PN, Trautwein C, Cetin Y, Maschek H, Stolte M, Gebel M, Manns MP: Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996;28:1-13. (Pubitemid 26040136)
2. Carvalho AT, Elia CC, de Souza HS, Elias PR, Pontes EL, Lukashok HP, de Freitas FC, Lapa e Silva JR: Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease. J Clin Gastroenterol 2003;36:120-125. (Pubitemid 36139723)
3. Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, Bonis P, Hassall E, Straumann A, Rothenberg ME: Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007;133:1342-1363.
4. Straumann A, Simon HU: Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol 2005;115:418-419.
5. Spergel JM: Eosinophilic esophagitis in adults and children: evidence for a food allergy component in many patients. Curr Opin Allergy Clin Immunol 2007;7:274-278.
6. Gauvreau GM, Ellis AK, Denburg JA: Haemopoietic processes in allergic disease: eosinophil/basophil development. Clin Exp Allergy 2009;39:1297-1306.
7. Kato M, Kephart GM, Talley NJ, Wagner JM, Sarr MG, Bonno M, McGovern TW, Gleich GJ: Eosinophil infiltration and degranulation in normal human tissue. Anat Rec 1998;252:418-425. (Pubitemid 28487881)
8. Lampinen M, Carlson M, Hakansson LD, Venge P: Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004;59:793-805. (Pubitemid 39005818)
9. Plotz SG, Traidl-Hoffmann C, Feussner I, Kasche A, Feser A, Ring J, Jakob T, Behrendt H: Chemotaxis and activation of human peripheral blood eosinophils induced by pollen-associated lipid mediators. J Allergy Clin Immunol 2004;113:1152-1160. (Pubitemid 38857999)
10. Redvall E, Bengtsson U, Wenneras C: Responsiveness of eosinophils to aeroallergens may be independent of atopic status. Scand J Immunol 2008;67:377-384.
11. Svensson L, Redvall E, Bjorn C, Karlsson J, Bergin AM, Rabiet MJ, Dahlgren C, Wenneras C: House dust mite allergen activates human eosinophils via formyl peptide receptor and formyl peptide receptor-like 1. Eur J Immunol 2007;37:1966-1977. (Pubitemid 47065132)
12. Svensson L, Wenneras C: Human eosinophils selectively recognize and become activated by bacteria belonging to different taxonomic groups. Microbes Infect 2005;7:720-728. (Pubitemid 40720428)
13. Stenfeldt AL, Wenneras C: Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils. Immunology 2004;112:605-614.
14. Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O'Byrne PM: Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985-993.
15. Shichijo K, Makiyama K, Wen CY, Matsuu M, Nakayama T, Nakashima M, Ihara M, Sekine I: Antibody to eosinophil cationic protein suppresses dextran sulfate sodium-induced colitis in rats. World J Gastroenterol 2005;11:4505-4510. (Pubitemid 41150390)
16. Heatley RV, James PD: Eosinophils in the rectal mucosa. A simple method of predicting the outcome of ulcerative proctocolitis? Gut 1979;20:787-791. (Pubitemid 10223116)
17. Flood-Page P, Menzies-Gow A, Phipps S, Ying S, Wangoo A, Ludwig MS, Barnes N, Robinson D, Kay AB: Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003;112:1029-1036. (Pubitemid 38056318)
18. Jacobsen EA, Taranova AG, Lee NA, Lee JJ: Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J Allergy Clin Immunol 2007;119:1313-1320. (Pubitemid 46855871)
19. Svensson L, Dahlgren C, Wenneras C: The chemoattractant Trp-Lys-Tyr-Met-Val-D-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1. J Leukoc Biol 2002;72:810-818. (Pubitemid 36277853)
20. Roederer M: Compensation in flow cytometry; in Robinson JP: Current Protocols in Cytometry. New York, John Wiley and Sons, 2002, suppl 22, pp 1.14.11-11.14.20.
21. Eriksson L, Antti H, Gottfries J, Holmes E, Johansson E, Lindgren F, Long I, Lundstedt T, Trygg J, Wold S: Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Anal Bioanal Chem 2004;380:419-429.
22. Heinemann A, Schuligoi R, Sabroe I, Hartnell A, Peskar BA: Delta 12-prostaglandin J 2, a plasma metabolite of prostaglandin D 2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis. J Immunol 2003;170:4752-4758. (Pubitemid 36519984)
23. Straumann A, Conus S, Grzonka P, Kita H, Kephart G, Bussmann C, Beglinger C, Smith DA, Patel J, Byrne M, Simon HU: Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut 2010;59:21-30.
24. Alam R, Stafford S, Forsythe P, Harrison R, Faubion D, Lett-Brown MA, Grant JA: RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993;150:3442-3448.
25. Straumann A, Bauer M, Fischer B, Blaser K, Simon HU: Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol 2001;108:954-961. (Pubitemid 33151548)
26. Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, Jameson SC, Kirby C, Konikoff MR, Collins MH, Cohen MB, Akers R, Hogan SP, Assa'ad AH, Putnam PE, Aronow BJ, Rothenberg ME: Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006;116:536-547. (Pubitemid 43228372)
27. Zimmermann N, Rothenberg ME: Receptor internalization is required for eotaxin-induced responses in human eosinophils. J Allergy Clin Immunol 2003;111:97-105. (Pubitemid 36143298)
28. Kim JT, Gleich GJ, Kita H: Roles of CD9 molecules in survival and activation of human eosinophils. J Immunol 1997;159:926-933. (Pubitemid 127484247)
29. Abdelilah SG, Bouchaïb L, Morita M, Delphine A, Marika S, André C, Monique C: Molecular characterization of the low-affinity IgE receptor Fc epsilonRII/CD23 expressed by human eosinophils. Int Immunol 1998;10:395-404. (Pubitemid 28182096)
30. Vicario M, Blanchard C, Stringer KF, Collins MH, Mingler MK, Ahrens A, Putnam PE, Abonia JP, Santos J, Rothenberg ME: Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut 2010;59:12-20.
31. Bonnefoy JY, Gauchat JF, Life P, Graber P, Aubry JP, Lecoanet-Henchoz S: Regulation of IgE synthesis by CD23/CD21 interaction. Int Arch Allergy Immunol 1995;107:40-42.
32. van der Heijden FL, Joost van Neerven RJ, van Katwijk M, Bos JD, Kapsenberg ML: Serum-IgE-facilitated allergen presentation in atopic disease. J Immunol 1993;150:3643-3650. (Pubitemid 23129745)
33. Hansel TT, De Vries IJ, Carballido JM, Braun RK, Carballido-Perrig N, Rihs S, Blaser K, Walker C: Induction and function of eosinophil intercellular adhesion molecule-1 and HLA-DR. J Immunol 1992;149:2130-2136.
34. Akuthota P, Wang HB, Spencer LA, Weller PF: Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clin Exp Allergy 2008;38:1254-1263. (Pubitemid 352019674)
35. Lampinen M, Backman M, Winqvist O, Rorsman F, Ronnblom A, Sangfelt P, Carlson M: Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis. J Leukoc Biol 2008;84:1392-1399. (Pubitemid 352774474)
36. Coppi LC, Thomazzi SM, de Ayrizono ML, Coy CS, Fagundes WJ, Goes JR, Franchi GC, Jr., Nowill AE, Montes CG, Antunes E, Ferraz JG: Comparative study of eosinophil chemotaxis, adhesion, and degranulation in vitro in ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 2007;13:211-218. (Pubitemid 46806230)
37. Ahrens R, Waddell A, Seidu L, Blanchard C, Carey R, Forbes E, Lampinen M, Wilson T, Cohen E, Stringer K, Ballard E, Munitz A, Xu H, Lee N, Lee JJ, Rothenberg ME, Denson L, Hogan SP: Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis. J Immunol 2008;181:7390-7399.
38. Bochner BS: Systemic activation of basophils and eosinophils: markers and consequences. J Allergy Clin Immunol 2000;106:S292-S302.
39. Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS: Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003;167:199-204. (Pubitemid 36076080)
40. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, Pavord ID: Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973-984.